Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: Results of a multicenter study in Japan

Cancer

Volumn 118, Issue 14, 2012, Pages 3477-3483

  Tamaki, Yasuhiro ^a   Sato, Nobuaki ^b   Homma, Keiichi ^b   Takabatake, Daisuke ^c   Nishimura, Rieko ^c   Tsujimoto, Masahiko ^d   Yoshidome, Katsuhide ^d   Tsuda, Hitoshi ^e   Kinoshita, Takayuki ^e   Kato, Hironori ^f   Taniyama, Kiyomi ^f   Kamio, Takako ^g   Nakamura, Seigo ^h   Akiyama, Futoshi ⁱ   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h SHOWA UNIVERSITY   (Japan)

ⁱ CANCER INSTITUTE   (Japan)

Author keywords

breast; cytokeratin; messenger RNA; metastasis; one step nucleic acid amplification assay; sentinel

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; FEMALE; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; JAPAN; LABORATORY DEVICE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; ONE STEP NUCLEIC ACID AMPLIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; JAPAN; KERATIN-19; LYMPHATIC METASTASIS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; RNA; SENTINEL LYMPH NODE BIOPSY;

EID: 84863325178     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26683     Document Type: Article

References (28)

1. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23: 7703-7720. (Pubitemid 46291835)
2. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year result of a randomized controlled study. Ann Surg. 2010; 251: 595-600.
3. Schwarts G, Giuliano AE, Veronesi U,; the Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 2002; 94: 2542-2551. (Pubitemid 34478066)
4. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007; 13: 4807-4816. (Pubitemid 47294788)
5. Blumencranz P, Whitworth PW, Deck K, et al. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg. 2007; 194: 426-432. (Pubitemid 47370997)
6. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008; 122: 2562-2567. (Pubitemid 351590490)
7. Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res. 2009; 15: 2879-2884.
8. Schem C, Maass N, Bauershlag DO, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German Study Group. Virchows Arch. 2009; 454: 203-210.
9. Snook KL, Layer GT, Jackson PA, et al. the OSNA Study Group. Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg. 2011; 98: 527-535.
10. Khaddage A, Berremila SA, Forest F, et al. Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer. Anticancer Res. 2011; 31: 585-590.
11. Feldman S, Krishnamurthy S, Gillanders W, et al. the US One Step Nucleic Acid Amplification Clinical Study Group. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer. 2011; 117: 2599-2607.
12. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol. 2008; 26: 3338-3345.
13. Viale G, Dell'Orto P, Biaji MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time-reverse-transcription- polymerase chain reaction assay for mamaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008; 247: 136-142.
14. Martinez MMD, Veys I, Majjaj S, et al. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol. 2009; 35: 387-392.
15. Mansel RE, Goyal A, Douglas-Jones A, et al. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat. 2009; 115: 595-600.
16. Chu PG, Weiss LM,. Keratin expression in human tissues and neoplasms. Histopathology. 2002; 40: 403-439. (Pubitemid 34535443)
17. Parikh RP, Yang Q, Higgins SA, Haffty BG,. Outcomes in young women with breast cancer or triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys. 2008; 70: 35-42. (Pubitemid 350251027)
18. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM,. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008; 95: 547-554.
19. de Boer M, van Dijck JAAM, Bult P, Borm GF, Tjan-Heijnen VCG,. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010; 102: 410-425.
20. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L,. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the Prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Col Surg. 2009; 208: 333-340.
21. Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009; 27: 4679-4684.
22. Weaver DL, Ashikaga T, Krag DN, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 2010; 364: 412-421.
23. de Boer M, van Deurzen CHM, van Dijck JAAM, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009; 361: 653-663.
24. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011; 305: 569-575.
25. Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005; 241: 319-325.
26. Turner RR, Chu KU, Botnick LE, Hansen NM, Glass EC, Giuliano AE,. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000; 89: 574-581. (Pubitemid 30640103)
27. Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer. 2003; 98: 2307-2315. (Pubitemid 37466644)
28. Kumar S, Bramlage M, Jacks LM, Goldberg JI, Patil SM, Giri DD, Van Zee KJ,. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease. Ann Surg Oncol. 2010; 17: 2909-2919.